Stockreport

Bristol Myers Squibb Zeposia shows long-term efficacy [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Results from two phase 3 trials showed that switching from interferon beta-1a (IFN-ß) to Zeposia consistently led to reduced rates of whole brain volume loss at 24 mont [Read more]